Nutrition
Volume 19, Issue 1 , Pages 47-53 , January 2003

Lack of effects by tricyclic antidepressant and serotonin inhibitors on anorexia in MCG 101 tumor-bearing mice with eicosanoid-related cachexia

  • Wenhua Wang, MD

      Affiliations

    • Surgical Metabolic Research Laboratory at the Lundberg Laboratory for Cancer Research, Department of Surgery, Sahlgrenska University Hospital, Göteborg, Sweden
    • ,
  • Anna Danielsson

      Affiliations

    • Surgical Metabolic Research Laboratory at the Lundberg Laboratory for Cancer Research, Department of Surgery, Sahlgrenska University Hospital, Göteborg, Sweden
    • ,
  • Elisabeth Svanberg, MD, PhD

      Affiliations

    • Surgical Metabolic Research Laboratory at the Lundberg Laboratory for Cancer Research, Department of Surgery, Sahlgrenska University Hospital, Göteborg, Sweden
    • ,
  • Kent Lundholm, MD, PhD

      Affiliations

    • Surgical Metabolic Research Laboratory at the Lundberg Laboratory for Cancer Research, Department of Surgery, Sahlgrenska University Hospital, Göteborg, Sweden
    • Corresponding Author InformationCorrespondence to: Kent Lundholm, MD, PhD, Department of Surgery, Sahlgrenska University Hospital, SE 413 45 Göteborg, Sweden.

References 

  1. Blundell JE. Serotonin and appetite. Neuropharmacology. 1984;23:1537
  2. Krause R, James JH, Ziparo V, Fischer JE. Brain tryptophan and the neoplastic anorexia-cachexia syndrome. Cancer. 1979;44:1003
  3. Chance WT, Zhang FH, Foley-Nelson T, Fischer JE. Hyperammonemia and anorexia in Morris hepatoma-bearing rats. Physiol Behav. 1991;50:397
  4. Blaha V, Yang ZJ, Meguid MM, et al.  Ventromedial nucleus of hypothalamus is related to the development of cancer-induced anorexia (in vivo microdialysis study). Acta Med. 1998;41:3
  5. McCann UD, Yuan J, Hatzidimitriou G, Ricaurte GA. Selective serotonin reuptake inhibitors dissociate fenfluramine’s anorectic and neurotoxic effects (importance of dose, species and drug). J Pharmacol Exp Ther. 1997;281:1487
  6. Laviano A, Cangiano C, Preziosa I, et al.  Serotoninergic block in the ventromedial nucleus of hypothalamus improves food intake in anorectic tumor bearing rats. Adv Exp Med Biol. 1996;398:551
  7. Chance WT, von Meyenfeldt M, Fischer JE. Serotonin depletion by 5,7-dihydroxytryptamine or para-chloroamphetamine does not affect cancer anorexia. Pharmacol Biochem Behav. 1983;18:115
  8. Gietzen DW, Rogers QR, Leung PM, Semon B, Piechota T. Serotonin and feeding responses of rats to amino acid imbalance (initial phase). Am J Physiol. 1987;253:R763
  9. Gietzen DW, Duke CM, Hammer VA. Amino acid imbalance, a nutritional model (serotonin mediation of aversive responses). Physiol Behav. 1991;49:981
  10. Gietzen DW, Hammer VA, Beverly JL, Rogers QR. The role of serotonin (5-HT) in feeding responses to amino acids. Adv Exp Med Biol. 1991;294:389
  11. Laviano A, Cangiano C, Fava A, et al.  Peripherally injected IL-1 induces anorexia and increases brain tryptophan concentrations. Adv Exp Med Biol. 1999;467:105
  12. Garattini S, Guaitani A. Animal models for the study of cancer-induced anorexia. Cancer Treat Rep. 1981;65:23
  13. Wang W, Lönnroth C, Svanberg E, Lundholm K. Cytokine and cyclooxygenase-2 protein in brain areas of tumor-bearing mice with prostanoid-related anorexia. Cancer Res. 2001;61:4707
  14. Eden E, Lindmark L, Karlberg I, Lundholm K. Role of whole-body lipids and nitrogen as limiting factors for survival in tumor-bearing mice with anorexia and cachexia. Cancer Res. 1983;43:3707
  15. Lönnroth C, Gelin J, Lundholm K. Expression of interleukin-6 in tumor-bearing mice with cytokine dependent cachexia. Int J Oncol. 1994;5:329
  16. Lönnroth C, Svaninger G, Gelin J, et al.  Effects related to indomethacin prolonged survival and decreased tumor growth in a mouse tumor model with cytokine dependent cancer cachexia. Int J Oncol. 1995;7:1405
  17. Ekman L, Hellstrand K, Svaninger G, Henning M, Lundholm K. Brain serotonergic activity after treatment with β-adrenoceptor antagonists in the neoplastic anorexia syndrome. Abstract Eur Soc Clin Invest 1982; suppl.
  18. Matsumoto K, Mizowaki M, Suchitra T, et al.  Central antinociceptive effects of mitragynine in mice (contribution of descending noradrenergic and serotonergic systems). Eur J Pharmacol. 1996;317:75
  19. Rilke O, Will K, Jahkel M, Oehler J. Behavioral and neurochemical effects of anpirtoline and citalopram in isolated and group housed mice. Prog Neuropsychopharmacol Biol Psychiatry. 2001;25:1125
  20. Stenfors C, Yu H, Ross SB. Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram. Naunyn Schmiedebergs Arch Pharmacol. 2001;363:222
  21. Burke DH, Ryan RP. Cyproheptadine antagonism of p-chloroamphetamine hypothermia in mice. Eur J Pharmacol. 1986;129:195
  22. Paxinos G, Burt J, Atrens DM, Jackson DM. 5-hydroxytryptamine depletion with para-chlorophenylalanine (effects on eating, drinking, irritability, muricide, and copulation). Pharmacol Biochem Behav. 1977;6:439
  23. Woods SC, Figlewicz DP, Madden L, et al.  NPY and food intake (discrepancies in the model). Regul Pept. 1998;75–76:403
  24. Woods SC, Seeley RJ, Porte D, Schwartz MW. Signals that regulate food intake and energy homeostasis. Science. 1998;280:1378
  25. Lundholm K. Interactions of cytokines in the host. Acta Chir Scand. 1989;549(suppl):31
  26. Gelin J, Andersson C, Lundholm K. Effects of indomethacin, cytokines, and cyclosporin A on tumor growth and the subsequent development of cancer cachexia. Cancer Res. 1991;51:880
  27. Cahlin C, Korner A, Axelsson H, et al.  Experimental cancer cachexia (the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 B1 background and eicosanoid-dependent cachexia). Cancer Res. 2000;60:5488
  28. Moldawer LL, Georgieff M, Lundholm K. Interleukin 1, tumour necrosis factor-alpha (cachectin) and the pathogenesis of cancer cachexia. Clin Physiol. 1987;7:263
  29. Sherry BA, Gelin J, Fong Y, et al.  Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models. FASEB J. 1989;3:1956
  30. Gershenwald JE, Fong YM, Fahey TJ, et al.  Interleukin 1 receptor blockade attenuates the host inflammatory response. Proc Natl Acad Sci USA. 1990;87:4966
  31. Opara EI, Laviano A, Meguid MM, Yang ZJ. Correlation between food intake and CSF IL-1 alpha in anorectic tumor bearing rats. Neuroreport. 1995;6:750
  32. Laviano A, Gleason JR, Meguid MM, et al.  Effects of intra-VMN mianserin and IL-1ra on meal number in anorectic tumor-bearing rats. J Invest Med. 2000;48:40
  33. Anisman H, Zalcman S, Zacharko RM. The impact of stressors on immune and central neurotransmitter activity (bidirectional communication). Rev Neurosci. 1993;4:147
  34. Laviano A, Meguid MM, Yang ZJ, et al.  Cracking the riddle of cancer anorexia. Nutrition. 1996;12:706
  35. Mantovani G, Maccio A, Lai P, et al.  Cytokine involvement in cancer anorexia/cachexia (role of megastrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms). Crit Rev Oncog. 1998;9:99
  36. Cahlin C, Gelin J, Delbro D, et al.  Effect of cyclooxygenase and nitric oxide synthase inhibitors on tumor growth in mouse tumor models with and without cancer cachexia related to prostanoids. Cancer Res. 2000;60:1742
  37. Lundholm K, Gelin J, Hyltander A, et al.  Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res. 1994;54:5602
  38. McCarthy DO. Inhibitors of prostaglandin synthesis do not improve food intake or body weight of tumor-bearing rats. Res Nurs Health. 1999;22:380
  39. Squadrito F, Calapai G, Altavilla D, et al.  Central serotoninergic system involvement in the anorexia induced by NG-nitro-l-arginine, an inhibitor of nitric oxide synthase. Eur J Pharmacol. 1994;255:51
  40. Leibowitz SF. Brain monoamines and peptides (role in the control of eating behavior). Fed Proc. 1986;45:1396
  41. Leibowitz SF, Weiss GF, Shor-Posner G. Hypothalamic serotonin (pharmacological, biochemical, and behavioral analyses of its feeding-suppressive action). Clin Neuropharmacol. 1988;11:S51
  42. Chance WT, von Meyenfeldt MF, Fischer JE. Changes in brain amines associated with cancer anorexia. Neurosci Biobehav Rev. 1983;7:471
  43. Meguid MM, Muscaritoli M, Beverly JL, et al.  The early cancer anorexia paradigm (changes in plasma free tryptophan and feeding indexes). JPEN. 1992;16:56S
  44. Meguid MM, Fetissov SO, Varma M, et al.  Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition. 2000;16:843
  45. Schweiger U, Warnhoff M, Pahl J, Pirke KM. Effects of carbohydrate and protein meals on plasma large neutral amino acids, glucose, and insulin plasma levels of anorectic patients. Metabolism. 1986;35:938
  46. Chance WT, von Meyenfeldt M, Fischer JE. Delay of cancer anorexia following intraventricular injection of para-chlorophenylalanine. Pharmacol Biochem Behav. 1982;17:1043
  47. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res. 1996;711:163
  48. Shen Y, Connor TJ, Nolan Y, Kelly JP, Leonard BE. Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat. Life Sci. 1999;65:1773
  49. Xia Z, DePierre JW, Nassberger L. Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology. 1996;34:27
  50. Frazer A. Pharmacology of antidepressants. J Clin Psychopharmacol. 1997;17(suppl 1):2S
  51. Frazer A. Antidepressants. J Clin Psychiatry. 1997;58:9
  52. Ballinger A, El-Haj T, Perrett D, et al.  The role of medial hypothalamic serotonin in the suppression of feeding in a rat model of colitis. Gastroenterology. 2000;118:544
  53. Fantino M. Role of sensory input in the control of food intake. J Auton Nerv Syst. 1984;10:347
  54. Weber LJ. p-Chlorophenylalanine depletion of gastrointestinal 5-hydroxytryptamine. Biochem Pharmacol. 1970;19:2169
  55. Grignaschi G, Invernizzi RW, Fanelli E, et al.  Citalopram-induced hypophagia is enhanced by blockade of 5-HT(1A) receptors (role of 5-HT(2C) receptors). Br J Pharmacol. 1998;124:1781
  56. Hjorth S, Auerbach SB. 5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI). Behav Brain Res. 1996;73:281
  57. Kardinal CG, Loprinzi CL, Schaid DJ, et al.  A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia. Cancer. 1990;65:2657
  58. Bonhaus DW, Weinhardt KK, Taylor M, et al.  RS-102221 (a novel high affinity and selective, 5-HT2C receptor antagonist). Neuropharmacology. 1997;36:621
  59. Tecott LH, Sun LM, Akana SF, et al.  Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature. 1995;374:542

☆ This study was supported in part by grants from the Swedish Cancer Society (2014, 01PAA, 4261), the Swedish Research Council (08712, 13159, 13268), Tore Nilson Foundation, Assar Gabrielsson Foundation (AB Volvo), Jubileumskliniken Foundation, IngaBritt & Arne Lundberg Research Foundation, Swedish and Göteborg Medical Societies, and the Medical Faculty, Göteborg University.

PII: S0899-9007(02)00921-8

Nutrition
Volume 19, Issue 1 , Pages 47-53 , January 2003

Article Tools

* Image Usage & Resolution